Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Inovio Pharmaceuticals, Inc. (INO)

0.7718 -0.1568 (-16.89%)
At close: October 29 at 4:00:00 PM EDT
0.8785 +0.1067 (+13.82%)
Pre-Market: 9:14:40 AM EDT
Trade INO on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
65.3430
217.7560
832.0100
10,262.2680
Operating Expense
79,261.5710
86,887.4470
112,616.6780
134,258.6670
277,835.7880
Operating Income
-79,261.5710
-86,822.1040
-112,398.9220
-133,426.6570
-267,573.5200
Net Non Operating Interest Income Expense
1,804.8850
2,420.1600
4,589.1600
6,910.5010
3,528.0780
Other Income Expense
10,029.6380
-543.9570
555.6360
-8,601.1960
-13,607.4100
Pretax Income
-67,427.0480
-84,945.9010
-107,254.1260
-135,117.3520
-277,652.8520
Earnings from Equity Interest Net of Tax
--
--
--
0
-2,165.2130
Net Income Common Stockholders
-67,427.0480
-84,945.9010
-107,254.1260
-135,117.3520
-279,818.0650
Diluted NI Available to Com Stockholders
-67,427.0480
-84,945.9010
-107,254.1260
-135,117.3520
-279,818.0650
Basic EPS
-1.03
-1.81
-3.95
-6.09
-14.04
Diluted EPS
-1.03
-1.81
-3.95
-6.09
-14.04
Basic Average Shares
65,222.7320
46,886.4130
27,160.8630
22,173.6620
19,885.1820
Diluted Average Shares
65,222.7320
46,886.4130
27,160.8630
22,173.6620
19,885.1820
Total Operating Income as Reported
-79,261.5710
-86,822.1040
-112,398.9220
-143,940.0280
-267,573.5200
Total Expenses
79,261.5710
86,887.4470
112,616.6780
134,258.6670
277,835.7880
Net Income from Continuing & Discontinued Operation
-67,427.0480
-84,945.9010
-107,254.1260
-135,117.3520
-279,818.0650
Normalized Income
-84,480.2920
-86,553.9130
-112,139.9160
-130,454.6070
-271,971.8930
Interest Income
1,804.8850
2,420.1600
4,766.9930
8,133.2900
4,782.0300
Interest Expense
--
0
177.8330
1,222.7890
1,253.9520
Net Interest Income
1,804.8850
2,420.1600
4,589.1600
6,910.5010
3,528.0780
EBIT
-77,385.3680
-84,945.9010
-107,076.2930
-133,894.5630
-276,398.9000
EBITDA
-74,370.3080
-81,957.0710
-103,946.2510
-130,391.0250
-270,902.8740
Reconciled Depreciation
3,015.0600
2,988.8300
3,130.0420
3,503.5380
5,496.0260
Net Income from Continuing Operation Net Minority Interest
-67,427.0480
-84,945.9010
-107,254.1260
-135,117.3520
-279,818.0650
Total Unusual Items Excluding Goodwill
17,053.2440
1,608.0120
4,885.7900
-4,662.7450
-7,846.1720
Total Unusual Items
17,053.2440
1,608.0120
4,885.7900
-4,662.7450
-7,846.1720
Normalized EBITDA
-91,423.5520
-83,565.0830
-108,832.0410
-125,728.2800
-263,056.7020
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/8/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: